Sunwin Stevia International Inc (OTCMKTS:SUWN) Corrects On Impressive Volume

[[tagnumber 0]][[tagnumber 1]]We haven’t covered the stock of Sunwin Stevia International Inc (OTCMKTS:SUWN) for quite some time now. The reason for that is the fact that the ticker rarely makes significant percentile movements and the daily volumes are usually very small.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]In the beginning of April we saw [[tagnumber 6]]SUWN [[tagnumber 7]]slowly begin to make its way up the charts. With some hiccups the ticker gained around 100% by the beginning of this month. The ticker continued to ascend the charts, reaching new highs. The reason for the steady upward movement, however, was nowhere in sight.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]There were no new press releases and the only things you could find in the Yahoo! Finance feed of [[tagnumber 6]]SUWN [[tagnumber 7]]were SEC filings. This leads us to the review of the most recent numbers that [[tagnumber 6]]SUWN [[tagnumber 7]]recorded. Back in the end of January the company had:[[tagnumber 2]] [[tagnumber 17]] [[tagnumber 18]]cash: $392 thousand[[tagnumber 19]] [[tagnumber 18]]current assets: $10.37 million[[tagnumber 19]] [[tagnumber 18]]current liabilities: $7.16 million[[tagnumber 19]] [[tagnumber 18]]quarterly revenues: $4.77 million[[tagnumber 19]] [[tagnumber 18]]quarterly net loss: $324 thousand[[tagnumber 19]] [[tagnumber 28]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Now those are some decent numbers for an OTC markets entity, but we don’t see that much of a progress. Yes, the revenues have been increased, but so has the net loss. All the while the cash reserves of the company have been reduced significantly and the liabilities have gone up.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]And finally, after a long silence from company HQ we got some optimistic PR. In Tuesday [[tagnumber 6]]SUWN [[tagnumber 7]]issued a press release that announced a purchase order for enzyme–treated stevia products valued at over $3.2 million.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This didn’t provide much attention to the company stock and the next day the company informed us of a submitted patent application for the enzyme–treated stevia products. Despite the positive news, however, the market response was negative and we saw [[tagnumber 6]]SUWN [[tagnumber 7]]lose 11.84% and close at $0.335 on the biggest volume in more than three years of trading.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We see the ticker trying to recover in today’s session as it gapped up at $0.35, but it began to slide once again. In any case, doing your due diligence and weighing out the risks before putting any money on the line is crucial.[[tagnumber 2]]